NCT07425106

Comparative Study of High Performance Low-Cost Optical Coherence Tomography (Stage 1B, 2 and 3)

Enrolling by Invitation
NAAges 18–85InterventionalBasic science
Duke University
~82 participants
Updated 2026-02-25 on ClinicalTrials.gov
What's tested:retinal imaging with low-cost OCT-a/LCI device

At a glance

Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Number of Participants with Acceptable OCT Image Quality as Measured by Low-Cost OCT Device
Measured over during study procedures (30 minutes)
+2 more outcomes measured
Optical Coherence Tomography of Retina
Alzheimer Disease
1 sites across 1 states
North Carolina1
  • Adam Wax, Ph.D. · PRINCIPAL_INVESTIGATOR · Duke University

This trial hasn't published a contact. View it on ClinicalTrials.gov

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

able to provide informed consent

Exclusion

potentially confounding ocular conditions, such as: glaucoma, current corneal injury, retinal damage, diabetes, corrected distance visual acuity worse than 20/40
eyes that have had intraocular surgery or retinal surgery, other than cataract surgery
  • Number of Participants with Acceptable OCT Image Quality as Measured by Low-Cost OCT Deviceduring study procedures (30 minutes)

    measured by: ability to see clearly defined and recognizable structures of the retina with the low-cost OCT device.

  • RNFL Thicknessduring study procedures (30 minutes)

    Thickness of retinal nerve fiber layer, measured in microns

  • GCL Thicknessduring study procedures (30 minutes)

    Thickness of ganglion cell layer, measured in microns.